# About LuvThy Peptide — An Independent Sexual & Reproductive Research Desk > About LuvThy Peptide: an independent literature digest on two peptides studied for libido, arousal, and the reproductive hormone axis. How it is compiled, and what it is not — not a seller, not a clinic, not medical advice. An independent, citation-anchored digest of the sexual and reproductive research-peptide literature. Not a vendor. Not a clinic. Not medical advice. ## What LuvThy Peptide is LuvThy Peptide is an independent editorial reference desk covering the published research on two peptides studied in the context of **sexual desire, arousal, and the reproductive hormone axis**: PT-141 (bremelanotide) and kisspeptin. The site exists to make a clinically significant but frequently misrepresented literature legible — to tell a reader, in plain language and with citations, what each compound was actually studied for, in which populations, and how far that evidence reaches. The organizing idea is a two-level view of the same system. PT-141 acts at the brain-circuit level: it modulates the neural networks that process sexual motivation. Kisspeptin acts upstream: it activates the hypothalamic switch that sets the reproductive hormone cascade in motion. Reading them together gives a fuller picture than either one alone. Each compound has its own page, a comparison page lines them up side by side, and a single shared references list aggregates every source. Because these topics touch on sensitive areas — sexual health, reproductive medicine, and approved pharmaceuticals — this desk takes particular care to distinguish what is regulated from what is investigational, what is approved for specific populations from what is off-label, and what is cited clinical evidence from what is community-reported anecdote. Those distinctions are the point, not a disclaimer. ## How it is compiled Three principles govern what appears on this site. *First, everything is anchored to the peer-reviewed literature.* Every research claim is tied to a numbered citation — PubMed-indexed journal articles, clinical trial reports, regulatory documents — collected on the [references page](/references). Where a finding comes from a review rather than a primary study, the review is cited as such. *Second, the evidence is reported at its true strength, with regulatory context intact.* PT-141 carries an FDA approval for one specific indication in one specific population — that approval is reported accurately, along with everything outside its boundary. Kisspeptin is fully investigational — that status is reported plainly. Community field reports, where included, are explicitly labeled "anecdotal, not clinical evidence" and kept structurally separate from cited research findings. *Third, the two pages are cross-referenced.* Because both compounds operate in the same biological territory — desire, arousal, the reproductive axis — the pages link to one another so a reader can follow a mechanism or a question from one compound to the next. ## What it is not LuvThy Peptide is not a store, not a clinic, and not a source of medical advice. It does not sell, supply, source, or broker any peptide or research chemical, and it has no affiliate or referral relationship with any vendor. It does not employ clinicians, diagnose conditions, or prescribe anything. It does not recommend a dose, schedule, or route of administration for any person. The materials described here are either a prescription pharmaceutical (bremelanotide) that requires a licensed clinician and a specific diagnosis for appropriate use, or fully investigational research compounds (kisspeptin) with no approved indication. Readers interested in any condition described in the underlying research should consult a licensed clinician operating within their own jurisdiction, working with regulated, evidence-based options. This site provides a careful map of the literature — nothing more, and nothing it pretends to be. --- A clinician's-briefing digest of the sexual and reproductive research-peptide literature — citations sourced, never prescribed.